References
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65:5–29.
- Miller KD, Siegel RL, Lin CC, et al. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 2016;66:271–289.
- Assi T, El Rassy E, Tabchi S, et al. Treatment of cancer patients in their last month of life: aimless chemotherapy. Support Care Cancer. 2016;24:1603–1608.
- Group EBCTC. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. The Lancet. 2005;365:1687–1717.
- Sharp III TE, George JC. Stem cell therapy and breast cancer treatment: review of stem cell research and potential therapeutic impact against cardiotoxicities due to breast cancer treatment. Front in Oncol. 2014;4:299.
- Zhang R, Fan Q, Yang M, et al. Engineering melanin nanoparticles as an efficient drug–delivery system for imaging‐guided chemotherapy. Adv Mater. 2015;27:5063–5069.
- Wang Y, et al. ZnO‐functionalized upconverting nanotheranostic agent: multi‐modality imaging‐guided chemotherapy with on‐demand drug release triggered by pH. Angew Chem Int Ed Engl. 2015;54:536–540.
- Li S-Y, Sun R, Wang H-X, et al. Combination therapy with epigenetic-targeted and chemotherapeutic drugs delivered by nanoparticles to enhance the chemotherapy response and overcome resistance by breast cancer stem cells. J Control Release. 2015;205:7–14.
- Vahed SZ, et al. Liposome-based drug co-delivery systems in cancer cells. Mater Sci Eng C. 2017;71:1327–1341.
- Quinn JF, Whittaker MR, Davis TP. Glutathione responsive polymers and their application in drug delivery systems. Polym Chem. 2017;8:97–126.
- Shafiei-Irannejad V, et al. Reversion of multidrug resistance by co-encapsulation of doxorubicin and metformin in poly (lactide-co-glycolide)-d-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles. Pharm Res. 2018;35:119.
- Zeynabad FB, Salehi R, Mahkam M. Design of pH-responsive antimicrobial nanocomposite as dual drug delivery system for tumourtumour therapy. Appl Clay Sci. 2017;141:23–35.
- Rahimi M, Shafiei-Irannejad V, Safa KD, et al. Multi-branched ionic liquid-chitosan as a smart and biocompatible nano-vehicle for combination chemotherapy with stealth and targeted properties. Carbohydr Polym. 2018;196:299–312.
- Rahimi M, Safa KD, Salehi R. Co-delivery of doxorubicin and methotrexate by dendritic chitosan-g-mPEG as a magnetic nanocarrier for multi-drug delivery in combination chemotherapy. Polym Chem. 2017;8:7333–7350.
- Yang K, Feng L, Liu Z. Stimuli responsive drug delivery systems based on nano-graphene for cancer therapy. Adv Drug Deliv Rev. 2016;105:228–241.
- Nanda SS, Papaefthymiou GC, Yi DK. Functionalization of graphene oxide and its biomedical applications. Crit Rev Solid State Mater Sci. 2015;40:291–315.
- Liu J, Cui L, Losic D. Graphene and graphene oxide as new nanocarriers for drug delivery applications. Acta Biomater. 2013;9:9243–9257.
- Huskić M, Bolka S, Vesel A, et al. One-step surface modification of graphene oxide and influence of its particle size on the properties of graphene oxide/epoxy resin nanocomposites. Eur Polym J. 2018;101:211–217.
- Peng S, Liu C, Fan X. Surface modification of graphene oxide by carboxyl-group: preparation, characterization, and application for proteins immobilization. Integr Ferroelectr. 2015;163:42–53.
- Namvari M, Biswas CS, Wang Q, et al. Crosslinking hydroxylated reduced graphene oxide with RAFT-CTA: a nano-initiator for preparation of well-defined amino acid-based polymer nanohybrids. J Colloid Interface Sci. 2017;504:731–740.
- Torchilin VP. Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery. Nat Rev Drug Discov. 2014;13:813.
- Zhao Y, Zhou Y, Wang D, et al. pH-responsive polymeric micelles based on poly (2-ethyl-2-oxazoline)-poly (D, L-lactide) for tumour-targeting and controlled delivery of doxorubicin and P-glycoprotein inhibitor. Acta Biomater. 2015;17:182–192.
- Guo H-L, Wang X-F, Qian Q-Y, et al. A green approach to the synthesis of graphene nanosheets. ACS Nano. 2009;3:2653–2659.
- Rahimi M, Karimian R, Mostafidi E, et al. Highly branched amine-functionalized p-sulfonatocalix [4] arene decorated with human plasma proteins as a smart, targeted, and stealthy nano-vehicle for the combination chemotherapy of MCF7 cells. New J Chem. 2018;42:13010–13024.
- Shafiei‐Irannejad V, et al. Metformin enhances doxorubicin sensitivity via inhibition of doxorubicin efflux in P‐gp‐overexpressing MCF‐7 cells. Chem Biol Drug Des. 2018;91:269–276.
- Rahimi M, Safa KD, Alizadeh E, et al. Dendritic chitosan as a magnetic and biocompatible nanocarrier for the simultaneous delivery of doxorubicin and methotrexate to MCF-7 cell line. New J Chem. 2017;41:3177–3189.
- Yde CW, Issinger O-G. Enhancing cisplatin sensitivity in MCF-7 human breast cancer cells by down-regulation of Bcl-2 and cyclin D1. Int J Oncol. 2006;29:1397–1404.
- Rahimi M, Shojaei S, Safa KD, et al. Biocompatible magnetic tris (2-aminoethyl)amine functionalized nanocrystalline cellulose as a novel nanocarrier for anticancer drug delivery of methotrexate. New J Chem. 2017;41:2160–2168.